March 28, 2019 Phase II Trial Of Nintedanib In Patients With Bevacizumab-Resistant Recurrent Epithelial Ovarian, Tubal, And Peritoneal Cancer
March 26, 2019 Glial Activation Markers In CSF And Serum From Patients With Primary Progressive Multiple Sclerosis: Potential Of Serum GFAP As Disease Severity Marker?
March 26, 2019 Longitudinal Analysis Of Serum Neurofilament Light Chain: A Potential Therapeutic Monitoring Biomarker For Multiple Sclerosis
March 25, 2019 Methods For Type I Interferon Detection And Their Relevance For Clinical Utility And Improved Understanding Of Rheumatic Diseases